Cargando…
Amphetamine-Dextroamphetamine-Induced Cardiomyopathy, an Emerging Cause of Heart Failure in Young Patient Populations: A Case Study Involving the Study Drug
Amphetamine-Dextroamphetamine-induced cardiomyopathy has become an emerging cause of heart failure in teenage and young adult populations. With its increasingly widespread use for the treatment of attention-deficit/hyperactivity disorder (ADHD) as well as misuse as a “study drug” to increase concent...
Autores principales: | Lewars, Jennaire T, Wiarda, Karen P |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10368484/ https://www.ncbi.nlm.nih.gov/pubmed/37496550 http://dx.doi.org/10.7759/cureus.40942 |
Ejemplares similares
-
Dextroamphetamine-Amphetamine Augmentation in the Treatment of Treatment-Resistant Depression
por: Small, Tyler M, et al.
Publicado: (2022) -
Noninvasive Diagnostic Modalities in an Isolated Case of Cardiac Amyloidosis
por: Lewars, Jennaire, et al.
Publicado: (2021) -
Management of New Onset Amphetamine-Induced Acute Decompensated Heart Failure in a Young Adult: Case Report
por: Breier, Yuli, et al.
Publicado: (2023) -
Central serous chorioretinopathy associated with Adderall (dextroamphetamine-amphetamine) and topical steroid use
por: Alsberge, Joseph B., et al.
Publicado: (2022) -
Pneumatocele Manifestation in Early Recovery Period of COVID-19: A Case Study
por: Lewars, Jennaire
Publicado: (2023)